AT369987B - Verfahren zur herstellung einer pharmazeutischen zusammensetzung - Google Patents

Verfahren zur herstellung einer pharmazeutischen zusammensetzung

Info

Publication number
AT369987B
AT369987B AT0541377A AT541377A AT369987B AT 369987 B AT369987 B AT 369987B AT 0541377 A AT0541377 A AT 0541377A AT 541377 A AT541377 A AT 541377A AT 369987 B AT369987 B AT 369987B
Authority
AT
Austria
Prior art keywords
producing
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
AT0541377A
Other languages
English (en)
Other versions
ATA541377A (de
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of ATA541377A publication Critical patent/ATA541377A/de
Application granted granted Critical
Publication of AT369987B publication Critical patent/AT369987B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT0541377A 1976-07-27 1977-07-26 Verfahren zur herstellung einer pharmazeutischen zusammensetzung AT369987B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH958876 1976-07-27

Publications (2)

Publication Number Publication Date
ATA541377A ATA541377A (de) 1982-07-15
AT369987B true AT369987B (de) 1983-02-25

Family

ID=4353539

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0541377A AT369987B (de) 1976-07-27 1977-07-26 Verfahren zur herstellung einer pharmazeutischen zusammensetzung

Country Status (27)

Country Link
JP (1) JPS5315411A (de)
AR (1) AR216479A1 (de)
AT (1) AT369987B (de)
AU (1) AU515738B2 (de)
BE (1) BE857122A (de)
CA (1) CA1095833A (de)
CY (1) CY1261A (de)
DE (1) DE2732335C2 (de)
DK (1) DK325677A (de)
ES (1) ES461020A1 (de)
FI (1) FI772217A (de)
FR (1) FR2359607A1 (de)
GB (1) GB1589982A (de)
GR (1) GR65014B (de)
HK (1) HK81884A (de)
HU (1) HU178340B (de)
IE (1) IE45534B1 (de)
IL (1) IL52587A (de)
KE (1) KE3441A (de)
MY (1) MY8400057A (de)
NL (1) NL176227C (de)
NO (1) NO149874C (de)
NZ (1) NZ184722A (de)
PT (1) PT66850B (de)
SE (1) SE437469B (de)
SG (1) SG53884G (de)
ZA (1) ZA774536B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH649216A5 (de) * 1979-08-16 1985-05-15 Sandoz Ag Verfahren zur auftragung eines magensaftresistenten filmes auf einen heilmittelkern und feste einheitsdosierungsform mit magensaftresistentem film.
FR2471186A1 (fr) * 1979-12-10 1981-06-19 Roussel Uclaf Nouveaux comprimes a delitescence colique, ainsi que leur procede de preparation
JPS6056122B2 (ja) * 1980-05-21 1985-12-09 塩野義製薬株式会社 徐放性製剤
JPS5748908A (en) * 1980-09-08 1982-03-20 Kyorin Pharmaceut Co Ltd Prolonged release type nicomol pharmaceutical
US4795327A (en) * 1984-03-26 1989-01-03 Forest Laboratories, Inc. Controlled release solid drug dosage forms based on mixtures of water soluble nonionic cellulose ethers and anionic surfactants
US4540566A (en) * 1984-04-02 1985-09-10 Forest Laboratories, Inc. Prolonged release drug dosage forms based on modified low viscosity grade hydroxypropylmethylcellulose
JPS61254522A (ja) * 1985-05-02 1986-11-12 Takada Seiyaku Kk 錠剤組成物
JPS62246512A (ja) * 1986-04-18 1987-10-27 Fujisawa Pharmaceut Co Ltd 反復作用製剤
GB9714675D0 (en) * 1997-07-11 1997-09-17 Smithkline Beecham Plc Novel composition
DE19959419A1 (de) 1999-12-09 2001-06-21 Ratiopharm Gmbh Stabile galenische Zubereitungen umfassend ein Benzimidazol und Verfahren zu ihrer Herstellung
US20030113366A1 (en) * 2001-12-14 2003-06-19 Macgregor Alexander Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3148124A (en) * 1962-06-12 1964-09-08 William E Gaunt Method of preparing sustained release pharmaceutical tablets
CA927282A (en) * 1968-09-03 1973-05-29 S. Banker Gilbert Entrapment compositions and processes
GB1301849A (de) * 1969-12-15 1973-01-04
US3558768A (en) * 1969-12-19 1971-01-26 Sterling Drug Inc Sustained release pharmaceutical compositions

Also Published As

Publication number Publication date
SE437469B (sv) 1985-03-04
CA1095833A (en) 1981-02-17
NL176227C (nl) 1985-03-18
FR2359607B1 (de) 1980-02-22
NO149874B (no) 1984-04-02
KE3441A (en) 1984-09-14
PT66850A (fr) 1977-08-01
AU2730177A (en) 1979-02-01
ATA541377A (de) 1982-07-15
DK325677A (da) 1978-01-28
GB1589982A (en) 1981-05-20
BE857122A (fr) 1978-01-25
FI772217A (de) 1978-01-28
PT66850B (fr) 1979-03-13
HK81884A (en) 1984-11-25
NO149874C (no) 1984-07-11
AU515738B2 (en) 1981-04-30
ES461020A1 (es) 1979-05-01
NZ184722A (en) 1980-10-24
DE2732335A1 (de) 1978-02-02
DK325877A (da) 1978-01-20
NO772575L (no) 1978-01-30
MY8400057A (en) 1984-12-31
IL52587A0 (en) 1977-10-31
FR2359607A1 (fr) 1978-02-24
DE2732335C2 (de) 1983-01-20
NL176227B (nl) 1984-10-16
IE45534B1 (en) 1982-09-22
ZA774536B (en) 1979-02-28
SG53884G (en) 1985-03-08
IL52587A (en) 1980-09-16
HU178340B (en) 1982-04-28
IE45534L (en) 1978-01-27
AR216479A1 (es) 1979-12-28
NL7708162A (nl) 1978-01-31
JPS5315411A (en) 1978-02-13
GR65014B (en) 1980-06-13
JPS5726650B2 (de) 1982-06-05
SE7708265L (sv) 1978-01-28
CY1261A (en) 1984-11-23

Similar Documents

Publication Publication Date Title
AT360654B (de) Verfahren zur herstellung von pharmazeutischen zusammensetzungen
AT377438B (de) Verfahren zur herstellung einer pharmazeutischen zusammensetzung
AT381638B (de) Verfahren zur herstellung einer pharmazeutischen zusammensetzung zur topischen applikation
ATA932977A (de) Verfahren zur herstellung einer materialbahn
DD133519A5 (de) Verfahren zur herstellung eines stuetzverbands
ATA971776A (de) Verfahren zur herstellung eines stabilen antibiotischen praparates
ATA843476A (de) Verfahren zur herstellung einer stabilen lyopilisierbaren bzw. lyophilisierten erythro- zyten-praeparation
AT367295B (de) Verfahren zur herstellung von pharmazeutischen zusammensetzungen
AT369987B (de) Verfahren zur herstellung einer pharmazeutischen zusammensetzung
AT363177B (de) Verfahren zur herstellung einer stabilen thymosinfraktion 5
AT343276B (de) Verfahren zur herstellung einer antiviral wirksamen pharmazeutischen zusammensetzung
AT374682B (de) Verfahren zur herstellung einer pharmazeutischen zusammensetzung
DD137670A5 (de) Verfahren zur herstellung einer neuen pharmazeutischen zusammensetzung
AT343286B (de) Verfahren zur herstellung einer topischen zubereitung
AT358792B (de) Verfahren zur herstellung eines doppelbodens
LU78009A1 (de) Verfahren zur herstellung von thiazinderivaten
AT358723B (de) Verfahren zur herstellung eines lipasereichen enzympraeparates
AT368390B (de) Verfahren zur herstellung einer heterovakzine
AT347579B (de) Verfahren zur herstellung einer stabilen injizierbaren loesung
DD138506A1 (de) Verfahren zur herstellung einer waessrigen loesung
ATA328780A (de) Verfahren zur herstellung acylaminobenzoesaeurecerivaten
AT361527B (de) Verfahren zur herstellung eines verbundwerk- stoffes
PT65800A (de) Verfahren zur herstellung einer pharmazeutischen zubereitung
AT371711B (de) Verfahren zur herstellung einer pharmazeutischen zubereitung
DD130910A1 (de) Verfahren zur herstellung einer suessware

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee